Please login to the form below

Not currently logged in
Email:
Password:

fundraising

This page shows the latest fundraising news and features for those working in and with pharma, biotech and healthcare.

MSD taps Austria’s Themis to bolster vaccine pipeline

MSD taps Austria’s Themis to bolster vaccine pipeline

forward plans for a phase 3 chikungunya trial as it advances plans for additional fundraising.

Latest news

More from news
Approximately 1 fully matching, plus 73 partially matching documents found.

Latest Intelligence

  • Building Europe’s next breakthrough biotechs Building Europe’s next breakthrough biotechs

    on the world-class resources of Cambridge’s life sciences cluster to propel them towards their first truly significant - series A - fundraising. ... a difficult time, whilst also preparing them with the tools they need to secure their first truly major

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    She played a key role in Crescendo’s recent $70m fundraising project, has overseen finances and operations and, more recently, business development.

  • 30 Women Leaders in UK Healthcare (part 2) 30 Women Leaders in UK Healthcare (part 2)

    At Immunocore, Eva-Lotta contributed significantly to a $320m Series A fundraising in July 2015, at the time the largest in Europe and second-largest around in the world in the

  • European venture funding for the life science sector European venture funding for the life science sector

    runway and capital so companies can conduct the right trials, give themselves various exit options and ensure management is not distracted by fundraising every year. ... With venture fundraising in the US at a high, and the Nasdaq demonstrating a

  • Case study: Action on Fistula Case study: Action on Fistula

    A rolling internal and external communications campaign has resulted in 80 pieces of media coverage with a circulation of 95.1 million, and employees fundraising 23, 187 across 12 countries to

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

  • Enterprise Therapeutics appoints CEO Enterprise Therapeutics appoints CEO

    Discovery. Dr Peter Finan, chairman of Enterprise Therapeutics, said: “John's experience in ion channels, drug development, and biotech fundraising position him uniquely to lead Enterprise Therapeutics moving forward.

  • F2G appoints chief financial officer F2G appoints chief financial officer

    His strong track record in fundraising, M&A transactions and deal structuring will be invaluable as we continue to generate positive data from our clinical trials and position the company for

  • Consilium Strategic Communications appoints Chris Gardner Consilium Strategic Communications appoints Chris Gardner

    He has led communications strategies on multiple cross-border IPOs, private fundraisings and international M&A. .

  • Ex Sanofi boss joins Boston start-up Ex Sanofi boss joins Boston start-up

    His move follows an aggressive fundraising campaign for the firm, which has raised $107m in just four months. .

  • ReNeuron appoints new CEO ReNeuron appoints new CEO

    During this time he built a multinational leadership team at Clavis, taking the company's lead programme through phase III clinical development and completing substantial fundraising and out-licensing transactions for

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 19 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics